Decoding Autism Now · IMIG Initiative
Contact
Decoding Autism Now · IMIG Initiative

ContactThe right person for your inquiry

One person is leading this initiative clinically and scientifically. Depending on your role — funder, researcher, clinician, or press — there is a direct path. No forms. No gatekeeping.

Find your path
Who to contact and why
Funders
Foundation program officers, philanthropic investors, or pharma medical affairs contacts interested in the trial opportunity — contact Dr. Fourie directly. For trial infrastructure and coordination questions, the clinical research organisation contact will be added here when confirmed.
Researchers
Academic collaborators, immunologists, or neuroscientists interested in the mechanism or co-investigation — contact Dr. Fourie for scientific discussion.
Clinicians
Paediatricians or child psychiatrists with patients who may be candidates, or seeking clinical protocol details — contact Dr. Fourie. Clinical enquiries about existing patients go directly to Dr. Fourie.
Media / Press
Science journalists or content producers — contact Dr. Fourie for background and context, or use the science communication contact at quay@decodingautismnow.com.
The team
Principal Investigator
Dr. Pieter Rousseau Fourie
BSc. Eng. (Electrical) · M.B.Ch.B. · PhD (Medical Physiology) · M.Med. (Paediatrics)
Pr. Eng. · Senior Member IEEE · Fellow SAIEE

Consultant Paediatrician, South Africa. Author of the first published IMIG case report in ASD and PANS (Fourie & Armstrong, Medical Research Archives, 2024). Currently treating more than forty patients with IMIG, including children with profound Level 2 and 3 ASD. The scientific and clinical vision for this trial is Dr. Fourie's.

Email
pieter@innovation4life.com
Location
Durbanville, South Africa
Tel
+27 21-9754645
Practice
stix.co.za
Clinical Research Organisation
TASK Clinical, South Africa

TASK Clinical is an established clinical research organisation with a track record in paediatric and infectious disease trials. TASK is developing the formal trial protocol and budget in collaboration with Dr. Fourie. Trial infrastructure contact details will be published here when confirmed.

i

Research context — not clinical guidance. This initiative is focused on developing a clinical trial, not providing medical treatment. IMIG for ASD is investigational and not approved in any jurisdiction. Families seeking clinical guidance should consult a qualified paediatrician or child neurologist. Response times from South Africa (SAST, UTC+2) may vary depending on clinical schedules.